Skip to main content
 

AHA Innovators’ Network Member AliveCor receives unique Dual FDA clearance of AI that can detect life-threatening cardiac conditions

AHA Innovators’ Network Member AliveCor receives unique Dual FDA clearance of AI that can detect life-threatening cardiac conditions

AHA Innovators’ Network Member Company was granted an unique dual clearance from the FDA for the AI detection of
life-threatening cardiac conditions, including heart attacks.

Learn more here.

More News

  • AccurKardia Secures FDA 510(k) Clearance of and Launches AccurECG 2.0

  • Amplity joins Innovators’ Network at the American Heart Association’s Center for Health Technology & Innovation

  • MicroTransponder Announces Positive Medicare Payment Change for Vivistim® Procedure